SGA Global Growth Strategy Exited Its Holdings in Gartner (IT)
Sustainable Growth Advisers (SGA), an investment management company, released its first-quarter 2026 investor letter for its “Global Growth Strategy.” A copy of […]
Strategy
Strategy shares fall after selling $2.5 million in bitcoin, its first sale since 2022
Michael Saylor’s Strategy sold bitcoin last week for the second time ever as geopolitical uncertainty continues to weigh on the
1 Thing Investors Should Know About Meta’s New Subscription Strategy
Investors are increasingly anxious about the heavy capital expenditures (capex) required for artificial intelligence (AI) infrastructure, and rightfully so. It’s
The Strategy CEO Bitcoin Sale Conditions That Could Move $66 Billion in BTC
For many years, the conventional wisdom surrounding MicroStrategy, which is now just called Strategy, could fit on a bumper sticker.
Why 2026 Is the Year to Rethink Your College Savings Strategy
SOME CARD INFO MAY BE OUTDATED This page includes information about these cards, currently unavailable on NerdWallet. The information has
Featured
#712: The Rental Strategy That Survived Every City Crackdown, with Jeff Hurst
What if you could earn short-term rental yields without the short-term rental headaches? As major cities continue to regulate away
How Smart Is Your Gifting Strategy? Take Our Grandparents’ Legacy Quiz
(Image credit: Getty Images) Most grandparents think of gifting in terms of birthday checks or holiday envelopes. But for those
Soligenix (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach
Austin, Texas, United States, April 21st, 2026, FinanceWire By Christopher J. Schaber, chairman, president, and CEO, Soligenix; published via Clinical Leader Soligenix (NASDAQ:
Why Strategy Stock Leaped Almost 12% Higher on Friday
Strategy (MSTR +11.88%), a one-time pure tech company that has essentially morphed into a Bitcoin treasury operation, saw its stock
Lixte Biotech Holdings (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships
Austin, Texas, United States, April 10th, 2026, FinanceWire LIXT is advancing its lead candidate LB-100, a first-in-class therapy designed to